{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:15:47Z","timestamp":1788786947470,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,9]]},"DOI":"10.7759\/cureus.51924","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T10:33:57Z","timestamp":1704796437000},"source":"Crossref","is-referenced-by-count":3,"title":["The Correlation Between Serum Fibroblast Growth Factor 21 and the Severity and Occurrence of Coronary Artery Disease"],"prefix":"10.7759","author":[{"given":"Seema R","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R","family":"Keshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi V","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001890","article-title":"The role of FGF21 in the pathogenesis of cardiovascular disease","volume":"134","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Liu D, Long XX, Fang QC, Jia WP, Li HT. The role of FGF21 in the pathogenesis of cardiovascular disease. Chin Med J (Engl). 2021, 134:2931-43. 10.1097\/CM9.0000000000001890","journal-title":"Chin Med J (Engl)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui A","year":"2006","unstructured":"Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006, 86:515-81. 10.1152\/physrev.00024.2005","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nri2415","article-title":"The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models","volume":"8","author":"Weber C","year":"2008","unstructured":"Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008, 8:802-15. 10.1038\/nri2415","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00527.2015","article-title":"Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21","volume":"309","author":"Domouzoglou EM","year":"2015","unstructured":"Domouzoglou EM, Naka KK, Vlahos AP, Papafaklis MI, Michalis LK, Tsatsoulis A, Maratos-Flier E. Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. Am J Physiol Heart Circ Physiol. 2015, 309:H1029-38. 10.1152\/ajpheart.00527.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4564","article-title":"Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia\/reperfusion-induced injury in H9c2 cardiomyocytes","volume":"14","author":"Hu S","year":"2017","unstructured":"Hu S, Cao S, Liu J. Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia\/reperfusion-induced injury in H9c2 cardiomyocytes. Exp Ther Med. 2017, 14:771-9. 10.3892\/etm.2017.4564","journal-title":"Exp Ther Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12565","article-title":"Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature","volume":"40","author":"Crickx E","year":"2015","unstructured":"Crickx E, Saussine A, Vignon-Pennamen MD, Cordoliani F, Mouly F, Bagot M, Rybojad M. Diffuse dermal angiomatosis associated with severe atherosclerosis: two cases and review of the literature. Clin Exp Dermatol. 2015, 40:521-4. 10.1111\/ced.12565","journal-title":"Clin Exp Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50524","article-title":"Fibroblast growth factor 21: A more effective biomarker than free fatty acids and other insulin sensitivity measures for predicting non-alcoholic fatty liver disease in Saudi Arabian type 2 diabetes patients","volume":"15","author":"Bahijri S","year":"2023","unstructured":"Bahijri S, Eldakhakhny B, Enani S, et al.. Fibroblast growth factor 21: A more effective biomarker than free fatty acids and other insulin sensitivity measures for predicting non-alcoholic fatty liver disease in Saudi Arabian type 2 diabetes patients. Cureus. 2023, 15:50524. 10.7759\/cureus.50524","journal-title":"Cureus"},{"key":"ref8","article-title":"The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos G","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, et al.. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005, 1:219-27.","journal-title":"EuroIntervention"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.041","article-title":"The myth of the \"vulnerable plaque\": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment","volume":"65","author":"Arbab-Zadeh A","year":"2015","unstructured":"Arbab-Zadeh A, Fuster V. The myth of the \"vulnerable plaque\": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015, 65:846-55. 10.1016\/j.jacc.2014.11.041","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-304273","article-title":"Widening clinical applications of the SYNTAX Score","volume":"100","author":"Farooq V","year":"2014","unstructured":"Farooq V, Head SJ, Kappetein AP, Serruys PW. Widening clinical applications of the SYNTAX Score. Heart. 2014, 100:276-87. 10.1136\/heartjnl-2013-304273","journal-title":"Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.778615","article-title":"Predictive value of Gensini score in the long-term outcomes of patients with coronary artery disease who underwent PCI","volume":"8","author":"Wang KY","year":"2021","unstructured":"Wang KY, Zheng YY, Wu TT, Ma YT, Xie X. Predictive value of Gensini score in the long-term outcomes of patients with coronary artery disease who underwent PCI. Front Cardiovasc Med. 2021, 8:778615. 10.3389\/fcvm.2021.778615","journal-title":"Front Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2308","article-title":"Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease","volume":"101","author":"Li Q","year":"2016","unstructured":"Li Q, Zhang Y, Ding D, et al.. Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease. J Clin Endocrinol Metab. 2016, 101:4886-94. 10.1210\/jc.2016-2308","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5937\/jomb0-24662","article-title":"Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome","volume":"39","author":"Vasanthi M","year":"2020","unstructured":"Vasanthi M, Adole PS, Pandit VR, Vinod KV. Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome. J Med Biochem. 2020, 39:460-6. 10.5937\/jomb0-24662","journal-title":"J Med Biochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.01.004","article-title":"Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques","volume":"96","author":"An SY","year":"2012","unstructured":"An SY, Lee MS, Yi SA, et al.. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques. Diabetes Res Clin Pract. 2012, 96:196-203. 10.1016\/j.diabres.2012.01.004","journal-title":"Diabetes Res Clin Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen Y","year":"2013","unstructured":"Shen Y, Ma X, Zhou J, et al.. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease. Cardiovasc Diabetol. 2013, 12:124. 10.1186\/1475-2840-12-124","journal-title":"Cardiovasc Diabetol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12134","article-title":"Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status","volume":"80","author":"Lee Y","year":"2014","unstructured":"Lee Y, Lim S, Hong ES, et al.. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clin Endocrinol (Oxf). 2014, 80:57-64. 10.1111\/cen.12134","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref17","article-title":"Fibroblast growth factor 21 in prediction of coronary angiography result in stable coronary artery disease patients","volume":"10","author":"Stanc\u00edk M","unstructured":"Stanc\u00edk M. Fibroblast growth factor 21 in prediction of coronary angiography result in stable coronary artery disease patients. Biomed Res. 10:7-020.","journal-title":"Biomed Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181099","article-title":"Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris","volume":"38","author":"Cheng J","year":"2018","unstructured":"Cheng J, Su X, Qiao L, Zhai C, Chen W. Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris. Biosci Rep. 2018, 38:BSR20181099. 10.1042\/BSR20181099","journal-title":"Biosci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure","volume":"28","author":"Tucker W","year":"2023","unstructured":"Tucker W, Tucker B, Rye KA, Ong KL. Fibroblast growth factor 21 in heart failure. Heart Fail Rev. 2023, 28:261-72. 10.1007\/s10741-022-10268-0","journal-title":"Heart Fail Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2018.7.1.42","article-title":"Relationship between circulating FGF21 concentrations and the severity of coronary artery damage in subjects with cardiovascular disease","volume":"7","author":"Park SD","year":"2018","unstructured":"Park SD, Bae KH, Choi YK, et al.. Relationship between circulating FGF21 concentrations and the severity of coronary artery damage in subjects with cardiovascular disease. J Lipid Atheroscler. 2018, 7:42-9. 10.12997\/jla.2018.7.1.42","journal-title":"J Lipid Atheroscler"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3346%2Fjkms.2015.30.5.586","article-title":"Association between serum fibroblast growth factor 21 and coronary artery disease in patients with type 2 diabetes","volume":"30","author":"Kim WJ","year":"2015","unstructured":"Kim WJ, Kim SS, Lee HC, et al.. Association between serum fibroblast growth factor 21 and coronary artery disease in patients with type 2 diabetes. J Korean Med Sci. 2015, 30:586-90. 10.3346%2Fjkms.2015.30.5.586","journal-title":"J Korean Med Sci"},{"key":"ref22","article-title":"Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes","volume":"61","author":"Matuszek B","year":"2010","unstructured":"Matuszek B, Lenart-Lipi\u0144ska M, Duma D, Solski J, Nowakowski A. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes. Endokrynol Pol. 2010, 61:50-4.","journal-title":"Endokrynol Pol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.01.017","article-title":"Fibroblast growth factor 21 in cardio-metabolic disorders: A systematic review and meta-analysis","volume":"83","author":"Lakhani I","year":"2018","unstructured":"Lakhani I, Gong M, Wong WT, et al.. Fibroblast growth factor 21 in cardio-metabolic disorders: A systematic review and meta-analysis. Metabolism. 2018, 83:11-7. 10.1016\/j.metabol.2018.01.017","journal-title":"Metabolism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217904-the-correlation-between-serum-fibroblast-growth-factor-21-and-the-severity-and-occurrence-of-coronary-artery-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:15:53Z","timestamp":1707509753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217904-the-correlation-between-serum-fibroblast-growth-factor-21-and-the-severity-and-occurrence-of-coronary-artery-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.51924","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,9]]}}}